Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

London pre-open: Stocks seen down after Wall St losses; manufacturing PMIs eyed

(Sharecast News) - London stocks were set for more losses on Friday following another negative session on Wall Street on the back of recession fears. The FTSE 100 was called to open down 24 points at 7,145, with investors eyeing June manufacturing PMIs for the UK and eurozone.

Ipek Ozkardeskaya, senior analyst at Swissquote Bank, said: "The pain may not be over, as the Fed is expected to remain as aggressive as needed until it sees a material and a persistent softening in inflation. The problem is, inflation doesn't necessarily come from the demand side, meaning that even with an aggressive policy tightening, the Fed may not achieve its goal soon enough.

"So, what will happen now? Nothing new. Inflation will remain the major driving factor of the markets in the second half, and the overall market sentiment will hugely depend on inflation numbers."

In corporate news, Chemring said the UK's Serious Fraud Office had closed its investigation into the activities of its Chemring Technology Solutions subsidiary and associated persons.

Chemring stated it had "co-operated fully" with the SFO throughout the investigation, which was initially launched back in January 2018, and said it was "pleased" that the matter was now closed.

Oxford Biomedica has signed a new three-year deal which would facilitate potential future manufacturing opportunities for the AstraZeneca Covid-19 vaccine.

This represents an expansion of the original master supply and development agreement announced between the two companies in September 2020. Under the new deal, manufacturing of vaccines at Oxford manufacturing facility, Oxbox, will be available to AstraZeneca on an as-needed basis beyond 2022.

Share this article

Related Sharecast Articles

London midday: Stocks rise as broker notes lend a hand; US PCE eyed
(Sharecast News) - London stocks had edged further into the black by midday on Friday, with broker notes helping to lift the top-flight index, as investors eyed the release of US CPE figures.
London open: Stocks nudge up ahead of US PCE
(Sharecast News) - London stocks nudged up in early trade on Friday as investors mulled the latest UK house price and retail footfall data and eyed the release of US CPE figures.
London pre-open: Stocks to edge up ahead of US PCE
(Sharecast News) - London stocks were set to edge up at the open on Friday as investors eyed the release of the latest US CPE figures.
London close: Stocks reverse early losses ahead of US inflation data
(Sharecast News) - London stocks reversed earlier losses in the next to last trading session of May, with Auto Trader pacing gains on the back of well-received results.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.